retatrutide how to inject Where to Inject Retatrutide: Sites,

Clinical data for retatrutide shows injection site reactions in approximately 5 to 15 percent of participants, typically mild redness, itching, or small lumps that resolve within a day or two

But blood work is not a one-and-done situation

There are no published studies assessing the effects of GLP-1 medication microdosing, confirms Dr

Diabetologia (1993) 36:7414

Adding pyridoxine to compounded semaglutide may help patients tolerate the titration phase more comfortably, particularly during the first 8 weeks when nausea is most likely

Investigational Status Retatrutide is investigational and not FDA-approved as of April 2026